nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of PCR for fetal cell detection
|
Lo, Y.M.D. |
|
1996 |
47 |
S1 |
p. S73-S77 5 p. |
artikel |
2 |
Detection of β-core fragment in second trimester Down's syndrome pregnancies
|
Cole, Laurence |
|
1996 |
47 |
S1 |
p. S47-S48 2 p. |
artikel |
3 |
Detection of fetal erythroblasts in maternal blood by onestep gradient enrichment and immunocytochemical recognition
|
Oosterwijk, J.C. |
|
1996 |
47 |
S1 |
p. S95-S97 3 p. |
artikel |
4 |
Detection of ‘rare event’ fetal erythroblasts in maternal blood using automated microscopy
|
Tanke, H.J. |
|
1996 |
47 |
S1 |
p. S89-S93 5 p. |
artikel |
5 |
Detection rates and false positive rates for Down syndrome screening: how precisely can they be estimated?
|
Gray, J.C. |
|
1996 |
47 |
S1 |
p. S59-S61 3 p. |
artikel |
6 |
Down's syndrome epidemiology and risk estimation
|
Palomaki, Glenn E. |
|
1996 |
47 |
S1 |
p. S19-S26 8 p. |
artikel |
7 |
Early prenatal diagnosis of fetal aneuploidy using coelomic fluid
|
Atkinson, G. |
|
1996 |
47 |
S1 |
p. S103-S104 2 p. |
artikel |
8 |
Established markers in second trimester maternal serum
|
Cuckle, H. |
|
1996 |
47 |
S1 |
p. S27-S29 3 p. |
artikel |
9 |
Ethical aspects of non-invasive prenatal diagnosis: medical, market, or regulatory model?
|
Annas, George J. |
|
1996 |
47 |
S1 |
p. S5-S11 7 p. |
artikel |
10 |
Foreword
|
Van Lith, Jan M.M. |
|
1996 |
47 |
S1 |
p. S1- 1 p. |
artikel |
11 |
Isolation and genetic analysis of fetal nucleated red blood cells from maternal blood: the Baylor College of Medicine experience
|
Elias, Sherman |
|
1996 |
47 |
S1 |
p. S85-S88 4 p. |
artikel |
12 |
Isolation of fetal trophoblasts and nucleated erythrocytes from the peripheral blood of pregnant women for prenatal diagnosis of fetal aneuploides
|
Durrant, L.G. |
|
1996 |
47 |
S1 |
p. S79-S83 5 p. |
artikel |
13 |
Markers for Down's syndrome in early pregnancy
|
Van Lith, Jan M.M. |
|
1996 |
47 |
S1 |
p. S105-S109 5 p. |
artikel |
14 |
Overview of screening techniques
|
Chard, T. |
|
1996 |
47 |
S1 |
p. S3-S4 2 p. |
artikel |
15 |
Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?
|
Muller, Françoise |
|
1996 |
47 |
S1 |
p. S37-S39 3 p. |
artikel |
16 |
Quality assessment of a prenatal screening program
|
Knight, George J. |
|
1996 |
47 |
S1 |
p. S49-S53 5 p. |
artikel |
17 |
Reliability of trans-cervical recovery of placental cells from the lower uterine pole using a minimally invasive procedure. Evidence based on fetal sexing and analysis of recovered cell populations
|
Miller, David |
|
1996 |
47 |
S1 |
p. S99-S102 4 p. |
artikel |
18 |
Risk communication; the patient's view
|
Thornton, J.G. |
|
1996 |
47 |
S1 |
p. S13-S17 5 p. |
artikel |
19 |
Second trimester ultrasound markers for fetal aneuploidy
|
Bilardo, Caterina |
|
1996 |
47 |
S1 |
p. S31-S33 3 p. |
artikel |
20 |
Specific approaches to fetal cells isolation from maternal blood: Introduction
|
Leschot, N.J. |
|
1996 |
47 |
S1 |
p. S69-S72 4 p. |
artikel |
21 |
The diagnostic value of the triple test in the diagnosis of Down's syndrome
|
Mol, B.W.J. |
|
1996 |
47 |
S1 |
p. S55-S58 4 p. |
artikel |
22 |
The pathophysiology of Down's syndrome pregnancies
|
Newby, D. |
|
1996 |
47 |
S1 |
p. S67-S68 2 p. |
artikel |
23 |
The significance of placental pathology in pregnancies with unexplained abnormal concentrations of MSAFP or MShCG
|
Morssink, Leonard P. |
|
1996 |
47 |
S1 |
p. S63-S65 3 p. |
artikel |
24 |
Ultrasound screening for fetal trisomies at 10–14 weeks gestation
|
Pajkrt, E. |
|
1996 |
47 |
S1 |
p. S35-S36 2 p. |
artikel |
25 |
Urinary analysis for Down's syndrome: is the measurement of urinary β-core the future of biochemical screening for Down's syndrome
|
Iles, R.K. |
|
1996 |
47 |
S1 |
p. S41-S45 5 p. |
artikel |